Study proteins that may worsen fluid leaks in shock
Part of Brain & nervous system, Heart & circulation, Infections clinical trials.
This trial studies specific body proteins to understand why fluid can leak from blood vessels during dangerous shock after infection or heart problems. If you (or your representative) qualify, your team will collect information and possibly samples to see whether these proteins relate to recovery and treatment response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or a legal representative/family member) can give consent to join
- You are covered by the French social security system (not AME)
- You are an adult (18 or older) and not pregnant
- You have a serious circulation problem called shock, such as septic shock, cardiogenic shock, or after cardiac arrest
- You need medicines to keep blood pressure up (vasopressor or similar), and your blood lactate is above 2.0
- Your shock started within the last 12 hours (medicine started), not more than 12 hours before joining
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with a severe type of shock that affects both the heart and blood vessels, treated in the intensive care unit. It aims to understand how these patients recover and what factors impact their survival.
This trial examines how the renin-angiotensin-aldosterone system (a hormone system that helps control blood pressure) changes in patients with septic shock, compared to those with sepsis without shock, cardiogenic shock, and healthy volunteers. The goal is to better understand these changes and possibly improve treatment.
This trial tests whether using specific safety signals can prevent harm from too much fluid given during septic shock. It may help guide doctors to stop fluids at the right time.
This trial tests a special fluid management strategy for people in septic shock—a serious infection that causes very low blood pressure. It aims to improve blood flow to organs and help you recover.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This trial tests a new way to manage fluids and blood pressure medicines in patients with septic shock. It aims to find if using a specific blood flow measurement (capillary refill time) can improve outcomes compared to standard care.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.